- Phase II Study of Cyclophosphamide, Epirubicin, Vincristine, Prednisone, and Etoposide (CEOP-E) for Aggressive Non-Hodgkin 's Lymphoma
-
Kim JG, Sohn SK, Kim DH, Baek JH, Park TI, Lee KB
- KMID: 1778563
- J Korean Med Sci.
- 2004 Dec;19(6):820-825.
- doi: 10.3346/jkms.2004.19.6.820
The main objectives of the current study were to evaluate the efficacy and safety of a CEOP-E regimen for patients with aggressive non-Hodgkin's lymphoma (NHL). Fifty-one consecutive patients with newly... -
- CITED
-
- Close
- SHARE
-
- Close
